Completed PHASE2 INTERVENTIONAL 1-arm NCT01592786

An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Sponsor: Forest Laboratories

Conditions Asperger's Asperger's Disorder Autism Autism Spectrum Disorder (ASD) Autistic Disorder Pediatric Autism Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Interventions Memantine Hydrochloride (HCl)

Updated 7 times since 2017 Last updated: Jul 15, 2014 Started: Jun 30, 2012 Primary completion: Jul 31, 2013 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01592786, this PHASE2 trial focuses on Asperger's and Asperger's Disorder and remains completed. Sponsored by Forest Laboratories, it has been updated 7 times since 2012, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Forest Laboratories

Data source: Forest Laboratories

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Avon Lake, United States , Barcelona, Spain , Barranquilla, Colombia , Belgrade, Serbia , Bello, Colombia , Bogotá, Colombia , Bothell, United States , Boulder, United States , Bradenton, United States and 93 more locations